DIABETES INDUCED DERMATOLOGICAL MANIFESTATIONS AND THEIR ASSOCIATION WITH VASCULAR COMPLICATIONS

Authors

  • Muhammad Qaisar Butt KRL Hospital Islamabad, Pakistan
  • Mahwish Ahmed HBS Medical and Dental College, Islamabad, Pakistan https://orcid.org/0009-0004-3517-8404
  • Juwayria Omar Fazaia Medical College Islamabad, Pakistan
  • Hameed Mumtaz Durrani Shifa College of Medicine, Islamabad, Pakistan https://orcid.org/0009-0000-3242-2724
  • Muhammad Afzal Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan

DOI:

https://doi.org/10.55519/JAMC-S4-14506

Keywords:

Diabetes mellitus, dermatological manifestations, vascular complications, diabetic dermopathy, necrobiosis lipoidica diabeticorum, coronary artery disease, diabetic retinopathy.

Abstract

Background: Diabetes related skin diseases, microvascular complications or metabolic alterations are affecting a majority of diabetic individuals. The purpose of this study was to identify the proportion of patients who presented with dermatological manifestations and to determine associated macrovascular and microvascular complications such as CAD, LEAD and Diabetic retinopathy. Methods: The present study was a cross-sectional descriptive survey with 355 T2DM. Participants were divided into two groups: to compare the incidence of skin manifestations and their association with cardiovascular complications between the patients with dermatological manifestations (n = 136) and those without (n = 219). Demographic data and clinical data regarding HbA1c, diabetes duration, and treatment method of patients with type 2 diabetes were also assessed. Skin inspection detected findings such as diabetic dermopathy, presence of Huntley’s papules, and necrobiosis lipoidica diabeticorum. Vascular complications were ascertained clinically and by imaging. The data was analyzed by using descriptive and inferential tools chi-square test, independent sample t-test as well as logistic regression. Results: Diabetes induced dermatological manifestations (DDMs) were observed in 38, 3% of the patients with diabetic dermopathy as the most frequent condition in this study with Huntley’s papules and necrobiosis lipoidica diabeticorum following the same trend. The number of vascular complications were significantly higher in patients with DDMs compared to those without DDMs patients. CAD was detected in 28.8% of the patients with DDMs as compared to 18.2% without DDMs (p=0.008). LEAD was detected in 35.5% of patients with DDMs compared to 23.5% of those without DDMs; p<0.001. Choroidal detachment and retinopathy of 10.5% were more common in patients with DDMs compared to those without 4.0% (p=0.003). Necrobiosis lipoidica diabeticorum was strongly associated with diabetic retinopathy and nephropathy, with an odds ratio (OR) of 5.11 (p<0.001). Multivariable analysis confirmed that the presence of DDMs was an independent predictor of vascular complications with OR: 2.35 (p<0.001). Conclusions: The three DDMs; diabetic dermopathy, Huntley’s papules, and necrobiosis lipoidica diabeticorum are strongly linked with vascular complications in T2DM patients. Dermatological screening should be incorporated into the usual diabetes care to enable early assessment of patients with increased potential for developing vascular complications that affects their prognosis.

References

1. World Health Organization. Global report on diabetes. Geneva: World Health Organization; 2016.

2. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014 Feb;103(2):137-49.

3. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2015; 38(Supplement 1).

4. Vața D, Stanciu DE, Temelie-Olinici D, Porumb-Andrese E, Tarcau BM, Grecu VB, et al. Cutaneous Manifestations Associated with Diabetes Mellitus A Retrospective Study. Diseases. 2023; 11(3):106.

5. Duff M, Demidova O, Blackburn S, Shubrook J. Cutaneous manifestations of diabetes mellitus. Clin Diabetes. 2015 Jan;33(1):40-8.

6. Bolognia JL, Schaffer JV, Cerroni L, Kirtschig G, Bagot M, Lambert J, et al. Dermatology. Elsevier; 2017.

7. Furqan S, Kamani L, Jabbar A. Skin manifestations in diabetes mellitus. J Ayub Med Coll Abbottabad 2014;26(1):46-8.

8. Naik PP, Farrukh SN. Clinical Significance of Diabetic Dermatopathy. Diabetes Metab Syndr Obes. 2020 Dec 8;13:4823-7.

9. Bauer MF, Hirsch P, Bullock WK, Abul-Haj SK. Necrobiosis lipoidica diabeticorum. A cutaneous manifestation of diabetic microangiopathy. Arch Dermatol. 1964 Dec;90:558-66.

10. Lima AL, Illing T, Schliemann S, Elsner P. Cutaneous Manifestations of Diabetes Mellitus: A Review. Am J Clin Dermatol. 2017 Aug;18(4):541-53.

11. Shamsi F, Jafri M, Tariq A, Imran M, Saeed S, Khan M, et al. Association of necrobiosis lipoidica diabeticorum with diabetic retinopathy and nephropathy: a case-control study. Dermatol Res Pract. 2020; 2020:6480109.

12. Fernandes J, Costa D, Costa F, Marques P, Gomes J, Silva J, et al. The clinical impact of skin changes in diabetic patients: a review of diabetic dermopathy and its vascular implications. J Diabetes Metab Disord. 2020; 19(1):293-303.

13. Rees JM, Scott IC, Treadwell J, Hutton J, Williams R, Dawson D, et al. Cutaneous signs in diabetes and their association with vascular complications. Diabet Med. 2017; 34(6):759-67.

14. Fuchs D, Dupon PP, Schaap LA. The association between diabetes and dermal microvascular dysfunction non-invasively assessed by laser Doppler with local thermal hyperemia: a systematic review with meta-analysis. Cardiovasc Diabetol. 2017;16:11. https://doi.org/10.1186/s12933-016-0487-1

15. Kota SK, Jammula S, Kota SK, Meher LK, Modi KD. Necrobiosis lipoidica diabeticorum: A case-based review of literature. Indian J Endocrinol Metab. 2012 Jul;16(4):614-20.

16. Baghaei F, Mirmohammadsadeghi A, Mohajeri S, Shabani M, Alinejad S, Shamsi F, et al. Cutaneous manifestations of diabetes mellitus and their correlation with metabolic parameters: a review article. J Clin Diagn Res. 2018;12(8)

17. Henry D, Singh A. A study of pattern of cutaneous manifestations in patients with diabetes mellitus. J Pak Assoc Dermatol. 2020;30(1):161-6.

18. Srutee B, Arun A, Nilanjan S, Joyeeta C, Abhijit B. Cutaneous Manifestations of Diabetes Mellitus in a Tertiary Care Hospital in Eastern India: A Cross-sectional Study. J Dermat Dermatologic Surg. 2024;28(1):29-32.

19. Samanta S, Wajid S, Chatterjee R, Bhadra S, Mukherjee S, Saha A, et al. A study on cutaneous manifestations of diabetes mellitus. Indian J Dermatol. 2018;63(6):489-93.

20. Lima AL, Illing T, Schliemann S. Cutaneous Manifestations of Diabetes Mellitus: A Review. Am J Clin Dermatol. 2017;18:541–53.

21. David P, Singh S, Ankar R. A comprehensive overview of skin complications in diabetes and their prevention. Cureus. 2023;15(5):e38961.

Published

2024-12-16

How to Cite

1.
Muhammad Qaisar Butt, Ahmed M, Omar J, Durrani HM, Afzal M. DIABETES INDUCED DERMATOLOGICAL MANIFESTATIONS AND THEIR ASSOCIATION WITH VASCULAR COMPLICATIONS. J Ayub Med Coll Abbottabad [Internet]. 2024 Dec. 16 [cited 2025 Jun. 2];36(4 (Suppl 1). Available from: https://jamc.ayubmed.edu.pk/index.php/jamc/article/view/14506